Feature | February 11, 2015

ACR Lung Screening Guidelines Improve on Study Findings

Lung-RADS guidelines would have reduced NLST false-positives by half

lung cancer, Lung-RADS, ACR, guidelines, study, CT, computed tomography

February 11, 2015 — A set of guidelines developed to help standardized lung cancer screening would have generated considerably fewer false-positives than the National Lung Screening Trial produced, according to a new retrospective study.

The guidelines, called Lung-RADS, were produced by the American College of Radiology (ACR) and are modeled after a similar set of guidelines for mammography screening for breast cancer.

“Lung-RADS was designed to reduce the percentage of positive lung screenings and thereby fewer false-positives, without missing clinically significant cancers. And in fact our analysis found it did,” says senior study author Ella Kazerooni, M.D., M.S., director of cardiothoracic radiology at the University of Michigan Health System.

“Fewer positive screenings means less follow-up testing for patients, which should further improve on the cost-effectiveness of lung cancer screening that was already demonstrated with NLST,” she adds.

Kazerooni led the ACR effort to create Lung-RADS, which was published in May 2014. It was developed to provide structured reporting, management and audit tools for practices across the country to follow and benchmark their performance against.

In the current study, the researchers applied the Lung-RADS criteria to the 48,671 lung screenings done as part of the National Lung Screening Trial, a large-scale clinical trial funded by the National Cancer Institute. That study found that computed tomography (CT) screening demonstrated a 20-percent reduction in lung cancer deaths among heavy smokers at high risk of lung cancer. Results appear in Annals of Internal Medicine.

Here, the researchers categorized the screenings according to Lung-RADS and found that 1 in 10 screenings would have been called positive, compared to 1 in 4 under the NLST. The false-positive rate was also lower under Lung-RADS, at 13 percent, compared to NLST at 27 percent.

The cancers that Lung-RADS missed looked to be slow-growing or minimally invasive. Researchers suspect that they would likely be caught on a subsequent routine screening with limited effect on survival.

“The high false-positive rate in the NLST is a potential harm. By implementing Lung-RADS, we may find that screening can be potentially even more effective,” Kazerooni says.

The study found that about half of the false-positive screens — along with the corresponding follow-up chest CT scans — from NLST would have been avoided under Lung-RADS. About a quarter of the false-positive screens that resulted in additional invasive tests would have been avoiding under Lung-RADS.

“The vast majority of screen detected lung nodules are not cancer,” says Douglas Arenberg, M.D., associate professor of pulmonary and critical care medicine at the University of Michigan Medical School. “Decades of experience have already provided us with a safe and very effective means of managing these so as to minimize unnecessary invasive procedures and anxiety among individuals found to have these incidental nodules.

Arenberg adds, “Lung-RADS takes advantage of this long history of managing incidental nodules and puts tools in the hands of providers for managing screen-detected abnormalities without having to refer everyone to a specialist. It also provides an added measure of safety for screened individuals knowing their follow up is guided by expert advice.”

For more information: www.umhealth.me/lungscreening

Related Content

Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Hitachi Supria True64 CT Receives FDA Clearance
Technology | Computed Tomography (CT) | September 15, 2017
September 15, 2017 — Hitachi Healthcare Americas Inc. announced it has attained U.S.
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT) | September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
Patient X-ray radiation exposure from medical imaging has been a hot topic in radiology and has prompted the implementation of radiation dose monitoring systems.
Feature | Radiation Dose Management | September 08, 2017 | By Dave Fornell
Patient X-ray radiation exposure from medical imaging has been a hot topic in radiology and has prompted the...
Overlay Init